Doug Hampton 
DUBLIN, June 2, 2023 /PRNewswire/ — The “Gene Editing Technologies Market – A Global and Regional Analysis: Focus on Offering, Technology, Application, End User, and Region – Analysis and Forecast, 2023-2032” report has been added to ResearchAndMarkets.com’s offering. The global gene editing technologies market was valued at $1.81 billion in 2022 and is anticipated to reach … Read more
NEW YORK, June 2, 2023 /PRNewswire/ — Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, announces preliminary data from a Phase 2 clinical trial of the company’s lead therapeutic candidate, PT-112, in patients with recurrent thymic epithelial tumors (TETs), specifically thymoma and thymic carcinoma. The trial is being conducted under … Read more
RADNOR, Pa., June 2, 2023 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced it will host a corporate and strategic update conference call on Monday, June 5, 2023 at 8:30 a.m. EDT. A live webcast of the conference call will be available on the Company’s website … Read more
SACRAMENTO, Calif., June 2, 2023 /PRNewswire/ — Legislation to improve physician oversight and give consumers rights at the Medical Board of California was approved by the state Senate 32-1 this week and moves ahead to the Assembly. The bill, SB 815 by Senator Richard Roth and Assemblymember Marc Berman, contains patient safety reforms long sought … Read more
Leading the Pack: Hannah Appoints Dr. Jaime Pickett to Drive Forward Innovative Membership-based Pet Healthcare Model in Portland, OR PORTLAND, Ore., June 2, 2023 /PRNewswire/ — Hannah Pet Hospital, a leading provider of innovative pet healthcare services, today announced the appointment of Dr. Jaime Pickett as its new Chief Executive Officer. Dr. Pickett brings over … Read more
MARLBOROUGH, Mass., June 2, 2023 /PRNewswire/ — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today announced the closing of its previously announced registered direct offering of 233,646 shares of common stock, at a purchase price … Read more
The company inks a deal to move to 11299 Illinois St. CARMEL, Ind., June 2, 2023 /PRNewswire/ — CNO Financial Group (NYSE: CNO) announced today that it will relocate its corporate headquarters to 11299 Illinois Street in Carmel, Indiana, from its current location at 11825 N. Pennsylvania Street in Carmel, Indiana. The move will take place … Read more
CHICAGO, June 2, 2023 /PRNewswire/ — The autoinjectors industry is set to experience significant growth in the near future as a result of several factors. With the rise in chronic diseases and the increasing need for self-administration of medication, autoinjectors have emerged as a convenient and efficient solution. These innovative devices enable patients to easily … Read more
Intense itching, pain, stress, shame… More than 2.5 million French people of all ages are affected by eczema, a stigmatizing disease surrounded by a lot of received ideas. A chronic skin disease, progressing in flare-ups, eczema is itchy, that is to say it causes intense itching. It is the redness, as well as the vesicles … Read more
the essential This specialty was provided by the doctors of the Clinique de Gascogne, who for a long time refused to come to work at the hospital. A partnership, which remains to be defined, would make it possible to maintain this care in the Gers. It was one of the biggest thorns in the side … Read more